» Articles » PMID: 27564982

Schnitzler Syndrome: Validation and Applicability of Diagnostic Criteria in Real-life Patients

Overview
Journal Allergy
Date 2016 Aug 27
PMID 27564982
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of neutrophil-mediated inflammation. The aim of this study was to assess the applicability and validity of the existing diagnostic criteria in real-life patients.

Methods: This multicentric study was conducted between 2009 and 2014 in 14 hospitals in which patients with Schnitzler syndrome or controls with related disorders were followed up. We compared the sensitivities and specificities and calculated the positive and negative predictive values of the Lipsker and of the Strasbourg criteria for the patients with Schnitzler syndrome and for the controls. We included 42 patients with Schnitzler syndrome, 12 with adult-onset Still's disease, 7 with cryopyrin-associated periodic disease, 9 with Waldenström disease, and 10 with chronic spontaneous urticaria.

Results: All patients with Schnitzler syndrome met the Lipsker criteria. According to the Strasbourg criteria, 34 patients had definite Schnitzler syndrome, five had probable Schnitzler syndrome, and three did not meet the criteria. One control met the Lipsker criteria and had probable Schnitzler syndrome according to the Strasbourg criteria. Sensitivity and specificity of the Lipsker criteria were 100% and 97%, respectively. For the Strasbourg criteria, sensitivity for definite and probable diagnosis was 81% and 93%, respectively, with a corresponding specificity of 100% and 97%.

Conclusion: Diagnostic criteria currently in use to diagnose Schnitzler syndrome are reliable. More investigations must be done to attest their efficiency in patients with recent-onset manifestations.

Citing Articles

Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome.

Muzes G, Sipos F Int J Mol Sci. 2025; 26(2).

PMID: 39859314 PMC: 11765222. DOI: 10.3390/ijms26020598.


Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging.

El Sadaney A, Dutta A, Cook J, Baffour F Diagnostics (Basel). 2024; 14(17).

PMID: 39272692 PMC: 11394483. DOI: 10.3390/diagnostics14171907.


Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management.

Braud A, Lipsker D Biomolecules. 2024; 14(6).

PMID: 38927050 PMC: 11202231. DOI: 10.3390/biom14060646.


Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.

Salugina S, Torgashina A, Borzova E, Rameev V, Gorodetsky V, Fedorov E Dokl Biochem Biophys. 2024; 517(1):214-227.

PMID: 38861148 DOI: 10.1134/S1607672924700923.


Case report: Schnitzler-like syndrome without monoclonal gammopathy.

Wesselmann A, Kunstner A, Fahnrich A, Rose C, Lamprecht P, Busch H Front Immunol. 2023; 14:1166620.

PMID: 37063861 PMC: 10097979. DOI: 10.3389/fimmu.2023.1166620.